Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davood Bashash

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Anti-Cancer Drugs|August 23, 2016
PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-MycElham Farhadi, Majid Safa, Ali M Sharifi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2020
Laboratory findings in COVID-19 diagnosis and prognosisAtieh Pourbagheri-Sigaroodi, Davood Bashash, Fatemeh Fateh, et al.
Molecular Biology Reports|November 4, 2023
C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cellsSara Zehtabcheh, Amir-Mohammad Yousefi, Majid Momeny, et al.
International Immunopharmacology|July 15, 2022
CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challengesAyda Baghery Saghchy Khorasani, Amir-Mohammad Yousefi, Davood Bashash
International Journal of Radiation Biology|December 15, 2020
Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approachFereshteh Koosha, Atieh Pourbagheri-Sigaroodi, Mohsen Bakhshandeh, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunitiesMitra Zabihi, Ramin Lotfi, Amir-Mohammad Yousefi, et al.
Molecular Biology Reports|February 9, 2022
Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cellsElham Ebrahimi, Rima Manafi Shabestari, Davood Bashash, et al.
Cell Biology International|May 30, 2024
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targetsRana Taheri, Yazdan Mokhtari, Amir-Mohammad Yousefi, et al.
Cell Biochemistry and Function|January 25, 2024
Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)Atieh Pourbagheri-Sigaroodi, Fatemeh Fallah, Davood Bashash, et al.
European Journal of Pharmacology|November 27, 2019
C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4Negar Sheikh-Zeineddini, Ava Safaroghli-Azar, Sina Salari, et al.
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Anti-Cancer Drugs|August 23, 2016
PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-κB and downregulation of Bcl-2, XIAP, and c-MycElham Farhadi, Majid Safa, Ali M Sharifi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2020
Laboratory findings in COVID-19 diagnosis and prognosisAtieh Pourbagheri-Sigaroodi, Davood Bashash, Fatemeh Fateh, et al.
Molecular Biology Reports|November 4, 2023
C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cellsSara Zehtabcheh, Amir-Mohammad Yousefi, Majid Momeny, et al.
International Immunopharmacology|July 15, 2022
CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challengesAyda Baghery Saghchy Khorasani, Amir-Mohammad Yousefi, Davood Bashash
International Journal of Radiation Biology|December 15, 2020
Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approachFereshteh Koosha, Atieh Pourbagheri-Sigaroodi, Mohsen Bakhshandeh, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2022
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunitiesMitra Zabihi, Ramin Lotfi, Amir-Mohammad Yousefi, et al.
Molecular Biology Reports|February 9, 2022
Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cellsElham Ebrahimi, Rima Manafi Shabestari, Davood Bashash, et al.
Cell Biology International|May 30, 2024
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targetsRana Taheri, Yazdan Mokhtari, Amir-Mohammad Yousefi, et al.
Cell Biochemistry and Function|January 25, 2024
Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)Atieh Pourbagheri-Sigaroodi, Fatemeh Fallah, Davood Bashash, et al.
European Journal of Pharmacology|November 27, 2019
C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4Negar Sheikh-Zeineddini, Ava Safaroghli-Azar, Sina Salari, et al.
Pageof 19